Mark Hull
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Infectious Diseases top 1%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in ⓘ
-
- HIV/AIDS Research and Interventions 82
- HIV/AIDS drug development and treatment 36
- Virology 27
- HIV Research and Treatment 26
- Co-authors
- Julio Montaner (40 shared papers)Joan Montaner (14 shared papers)Robert S. Hogg (28 shared papers)Marina B. Klein (29 shared papers)Curtis Cooper (28 shared papers)Nathan J. Lachowsky (28 shared papers)Viviane D. Lima (23 shared papers)Zunyou Wu (1 shared paper)
- Journals
- PLoS ONE (7 papers)Clinical Infectious Diseases (6 papers)Journal of the International AIDS Society (6 papers)AIDS (5 papers)International Journal of Drug Policy (4 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Mark Hull
130 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 132
- Hepatology 537
- Infectious Diseases 1.2k
- Virology 264
- Epidemiology 1.3k
- Emergency Medicine 316
Countries citing papers authored by Mark Hull
This map shows the geographic impact of Mark Hull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hull more than expected).
Fields of papers citing papers by Mark Hull
This network shows the impact of papers produced by Mark Hull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hull. The network helps show where Mark Hull may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hull, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 194 | |
| 2 | 2011 | 128 | |
| 3 | 2012 | 88 | |
| 4 | 2017 | 81 | |
| 5 | 2013 | 69 | |
| 6 | Struggling with paradoxes: the process of spiritual development in women with cancer. | 2002 | 61 |
| 7 | 2008 | 59 | |
| 8 | 2008 | 55 | |
| 9 | 2019 | 55 | |
| 10 | 2019 | 54 | |
| 11 | 2016 | 54 | |
| 12 | 2017 | 52 | |
| 13 | 2017 | 49 | |
| 14 | 2013 | 39 | |
| 15 | 2007 | 39 | |
| 16 | 2018 | 36 | |
| 17 | 2015 | 33 | |
| 18 | 2016 | 32 | |
| 19 | 2017 | 31 | |
| 20 | 2020 | 30 |
About Mark Hull
Mark Hull is a scholar working on Infectious Diseases, Virology, Hepatology, Epidemiology and Emergency Medicine, having authored 141 papers that have together received 2.2k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (82 papers), HIV, Drug Use, Sexual Risk (55 papers), Hepatitis C virus research (37 papers), HIV/AIDS drug development and treatment (36 papers), HIV Research and Treatment (26 papers), Sex work and related issues (22 papers), HIV-related health complications and treatments (21 papers) and Liver Disease Diagnosis and Treatment (19 papers). The work is most often cited by research in Hepatology (537 citations), Infectious Diseases (1.2k citations), Virology (264 citations), Epidemiology (1.3k citations) and Emergency Medicine (316 citations). Mark Hull has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Julio Montaner, Joan Montaner, Robert S. Hogg, Marina B. Klein, Curtis Cooper, Nathan J. Lachowsky, Viviane D. Lima, Zunyou Wu, Anthony W. Chow and Sharon Walmsley. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases, Journal of the International AIDS Society, AIDS and International Journal of Drug Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.